Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
34.62
+1.17 (3.50%)
At close: Jun 23, 2026, 4:00 PM EDT
35.31
+0.69 (1.99%)
After-hours: Jun 23, 2026, 4:25 PM EDT
Collegium Pharmaceutical Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Collegium Pharmaceutical stock has a consensus rating of "Buy" and an average price target of $54.33. The average 1-year stock price forecast is 56.93% higher than the current stock price, while the lowest is $45 (+29.98%) and the highest is $60 (+73.31%).
Price Target: $54.33 (+56.93%)
Analyst Consensus: Buy
* Price targets were last updated on May 13, 2026.
Analyst Ratings
The average analyst rating for Collegium Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 15, 2026 |
| Barclays | Barclays | Buy Reiterates $56 | Buy | Reiterates | $56 | +61.76% | May 13, 2026 |
| Needham | Needham | Buy Maintains $56 | Buy | Maintains | $56 | +61.76% | May 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 | Buy | Reiterates | $60 | +73.31% | May 8, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $44 | Hold | Maintains | $44 | +27.09% | Apr 23, 2026 |
Financial Forecast
Revenue This Year
874.57M
from 780.57M
Increased by 12.04%
Revenue Next Year
885.86M
from 874.57M
Increased by 1.29%
EPS This Year
7.72
from 7.42
Increased by 4.04%
EPS Next Year
7.61
from 7.72
Decreased by -1.40%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 882.6M | ||
| Avg | 874.6M | ||
| Low | 861.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.1% | ||
| Avg | 12.0% | ||
| Low | 10.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 7.72 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 4.0% | ||
| Low | - |